We studied the protection of recombinant human activated protein C (rhAPC) in endotoxin-induced lung inflammation and injury and whether this effect is correlated with modulation of lung matrix metalloproteinase (MMP) activity. We randomly assigned 12 Large White pigs to receive intravenous Escherichia coli lipopolysaccharide (LPS; 40 μg/kg/hr), rhAPC (24 μg/ kg/hr), or both. We monitored respiratory mechanics and function, cell counts, and cytokine concentrations in bronchoalveolar lavage fluid (BALF). Lung samples were collected for the zymography of MMP-2 and MMP-9 activities and for histology. In septic pigs, rhAPC decreased proMMP-9 release as well as MMP-9 activation, and increased proMMP-2 presence without any evident activation compared with specimens that were given LPS alone. In addition, lung injury in rhAPC-treated animals was significantly attenuated, as shown by higher respiratory compliance, delayed increase in tumor necrosis alfa and interleukin-1β as well as neutrophil recruitment in the BALF, reduced lung edema, and histologic changes. In conclusion, rhAPC is beneficial in acute lung injury, and the protection may depend, at least in part, on modulation of MMP-2/9 activity. Copyright
Activated protein C protection from lung inflammation in endotoxin-induced injury / F. Pirrone, S.M. Mazzola, C.V. Pastore, S. Paltrinieri, G. Sironi, P. Riccaboni, M. Viola, A. Passi, M.G. Clement, M. Albertini. - In: EXPERIMENTAL BIOLOGY AND MEDICINE. - ISSN 1535-3702. - 233:11(2008), pp. 1462-1468.
Activated protein C protection from lung inflammation in endotoxin-induced injury
F. PirronePrimo
;S.M. MazzolaSecondo
;C.V. Pastore;S. Paltrinieri;G. Sironi;P. Riccaboni;M.G. ClementPenultimo
;M. AlbertiniUltimo
2008
Abstract
We studied the protection of recombinant human activated protein C (rhAPC) in endotoxin-induced lung inflammation and injury and whether this effect is correlated with modulation of lung matrix metalloproteinase (MMP) activity. We randomly assigned 12 Large White pigs to receive intravenous Escherichia coli lipopolysaccharide (LPS; 40 μg/kg/hr), rhAPC (24 μg/ kg/hr), or both. We monitored respiratory mechanics and function, cell counts, and cytokine concentrations in bronchoalveolar lavage fluid (BALF). Lung samples were collected for the zymography of MMP-2 and MMP-9 activities and for histology. In septic pigs, rhAPC decreased proMMP-9 release as well as MMP-9 activation, and increased proMMP-2 presence without any evident activation compared with specimens that were given LPS alone. In addition, lung injury in rhAPC-treated animals was significantly attenuated, as shown by higher respiratory compliance, delayed increase in tumor necrosis alfa and interleukin-1β as well as neutrophil recruitment in the BALF, reduced lung edema, and histologic changes. In conclusion, rhAPC is beneficial in acute lung injury, and the protection may depend, at least in part, on modulation of MMP-2/9 activity. CopyrightPubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.